Evidence map›Paper›PMID 27886373›Full record

ArticleBritish journal of pharmacology2017

Clemizole hydrochloride blocks cardiac potassium currents stably expressed in HEK 293 cells.

Ling-Jun Jie, Wei-Yin Wu, Gang Li, Guo-Sheng Xiao, Shetuan Zhang, Gui-Rong Li, Yan Wang

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. AnFrontiers in pharmacology · 2018
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ling-Jun JieXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Wei-Yin WuXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Gang LiXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Guo-Sheng XiaoXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Shetuan ZhangDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada.
Gui-Rong LiXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.ORCID 0000-0002-9437-2280
Yan WangXiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
First Affiliated Hospital of Xiamen University · CNQueen's University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeClemizole, a histamine H EXPERIMENTAL APPROACH: Whole-cell patch techniques was used to examine the effects of clemizole on hERG channel current, I KEY

resultsClemizole decreased hERG current by blocking both open and closed states of the channel in a concentration-dependent manner (IC CONCLUSION AND IMPLICATIONS: Our results provide the first evidence that clemizole potently blocks hERG channels, moderately inhibits cardiac I

Indexed as

Action PotentialsAnimalsBenzimidazolesDose-Response Relationship, DrugElectrocardiographyEther-A-Go-Go Potassium ChannelsFemaleGuinea PigsHeart VentriclesHEK293 CellsHistamine H1 AntagonistsHumansInhibitory Concentration 50Long QT SyndromeMalePatch-Clamp TechniquesBenzimidazolesclemizoleEther-A-Go-Go Potassium ChannelsHistamine H1 AntagonistsPotassium Channel Blockers

Identifiers

PMID27886373
PMCPMC5241390
OpenAlexW2558506961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.